Myeloma and Related Diseases Registry (MRDR)

Please join us for the Annual MRDR Breakfast Meeting at Blood 2023, 7.00-8.15am AEDT. For details go to: Hope to see you there!

More information

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.


Patients accrued


Patients with multiple myeloma


Number of approved sites


M1000 Biobank participants

Latest news

MRDR Interest Group Breakfast Meeting at Blood 2023!
18 Aug 2023

Please join us for our annual Interest Group breakfast at Blood 2023, 6th November.

Read more
The Austin joins M1000
07 Aug 2023

The MRDR recruits another hospital for the Myeloma 1000 Project.

Read more
MY-PROMPT-2 is kicking goals!
19 Jun 2023

MY-PROMPT-2 project randomises first patient and enrols another!

Read more
Inferior outcomes in t(11;14) multiple myeloma
14 Jun 2023

Ken Lim's paper on Inferior outcomes in t(11;14) multiple myeloma has been accepted for publication.

Read more

Participating organisations